BSE Live
Apr 16, 13:26Prev. Close
725.65
Open Price
731.65
Bid Price (Qty.)
719.75 (9)
Offer Price (Qty.)
722.15 (5)
NSE Live
Apr 16, 13:26Prev. Close
727.60
Open Price
730.00
Bid Price (Qty.)
721.95 (2)
Offer Price (Qty.)
723.65 (15)
| Cash Flow of Albert David (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 15.72 | 12.18 | 11.93 | 14.65 | 11.87 | |
| Net CashFlow From Operating Activities | 16.94 | 20.38 | 7.67 | 3.39 | 14.09 | |
| Net Cash Used In Investing Activities | -13.18 | -8.61 | -24.41 | -16.27 | -21.39 | |
| Net Cash Used From Financing Activities | -4.93 | -2.63 | 18.80 | 6.51 | 1.28 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -1.18 | 9.14 | 2.06 | -6.36 | -6.03 | |
| Cash And Cash Equivalents Begin of Year | 16.22 | 7.08 | 5.03 | 11.39 | 17.42 | |
| Cash And Cash Equivalents End Of Year | 15.05 | 16.22 | 7.08 | 5.03 | 11.39 |
25.02.2026
Albert David Standalone December 2025 Net Sales at Rs 89.93 crore, up 8.24% Y-o-Y
13.11.2025
Albert David Standalone September 2025 Net Sales at Rs 87.24 crore, down 11.37% Y-o-Y
05.08.2025
Albert David Standalone June 2025 Net Sales at Rs 70.57 crore, down 21.03% Y-o-Y
13.05.2025
Albert David Standalone March 2025 Net Sales at Rs 74.89 crore, down 15.9% Y-o-Y
25.02.2026
Albert David Standalone December 2025 Net Sales at Rs 89.93 crore, up 8.24% Y-o-Y
13.11.2025
Albert David Standalone September 2025 Net Sales at Rs 87.24 crore, down 11.37% Y-o-Y
05.08.2025
Albert David Standalone June 2025 Net Sales at Rs 70.57 crore, down 21.03% Y-o-Y
13.05.2025
Albert David Standalone March 2025 Net Sales at Rs 74.89 crore, down 15.9% Y-o-Y
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth